Document Detail

Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation.
MedLine Citation:
PMID:  23283744     Owner:  NLM     Status:  Publisher    
The ErbB3 binding protein 1 (Ebp1) represents a downstream effector of the ErbB signaling network and has been demonstrated to be a potent tumor suppressor in various human malignancies, however, its involvement in human bladder cancer is still unclear.To investigate the clinical significance and potential role of ErbB3 binding protein 1 (Ebp1) in bladder cancer. Ebp1 expression at protein and gene levels in 52 surgically removed bladder cancer specimens as well as 21 adjacent normal bladder specimens were respectively detected by immunohistochemistry and qRT-PCR. The association of Ebp1 protein expression with the clinicopathological features of bladder cancer was also statistically analyzed. Its roles in bladder cancer cell line were further evaluated. The expression level of Ebp1 protein and gene in bladder cancer tissues was significantly lower than that in adjacent normal bladder tissues (P < 0.01). When categorized into low vs. high expression, the down-regulation of Ebp1 protein was associated with the advanced pathologic stage (P = 0.036) and the high histologic grade (P = 0.001) of patients with bladder cancer. Moreover, following the transfection of Ebp1 in bladder cancer cells, not only cell proliferation and cell invasion decreased significantly, but also the cell cycle was blocked at G0/G1 stage. Our data suggest for the first time that the down-regulation of Ebp1 closely correlates with advanced clinicopathological characteristics of human bladder cancer. Furthermore, Ebp1 plays an important role in the bladder cancer cells' proliferation by regulating the cancer cell cycle from G0/G1 to S.
Hui-Chan He; Xiao-Hui Ling; Jian-Guo Zhu; Xin Fu; Zhao-Dong Han; Yu-Xian Liang; Ye-Han Deng; Zhuo-Yuan Lin; Guo Chen; Yan-Fei Chen; Ru-Jun Mo; Wei-de Zhong
Related Documents :
23337504 - Mir-330 regulates the proliferation of colorectal cancer cells by targeting cdc42.
21426474 - Prospective trial to identify optimal bladder cancer surveillance protocol: reducing co...
24896324 - Methods for detection of circulating cells in non-small cell lung cancer.
24045224 - Emetine dihydrochloride: a novel therapy for bladder cancer.
16766394 - Serum levels of interleukin 1beta, interleukin 8 and tumour necrosis factor alpha as ma...
23388834 - Growth of confined cancer spheroids: a combined experimental and mathematical modelling...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-3
Journal Detail:
Title:  Molecular biology reports     Volume:  -     ISSN:  1573-4978     ISO Abbreviation:  Mol. Biol. Rep.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0403234     Medline TA:  Mol Biol Rep     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, 510180, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  NBS1 rs1805794G>C polymorphism is associated with decreased risk of acute myeloid leukemia in a Chin...
Next Document:  Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in...